Fig. 1From: Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysisStudy selection process according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelineBack to article page